JOHNSON & JOHNSON (JNJ) - Price, trends, fundamentals and chart - Passport to Wall Street

JOHNSON & JOHNSON (NYSE: JNJ)

Overview

current price

$159.92

$159.92

change

0.44 | 0.28%

0.44 | 0.28%

Yesterday's Close

159.48

open

157.83

volume

7.72 M

30d. avg volume.

7.52 M

1 day

157.54 - 160.11

52 weeks

133.65 - 173.65

p/e

28.94

beta

0.7260

market cap

419.86 B

dividend yield

2.53%

Industry

-

News and Commentary

FDA Calls for Temporary Pause of Johnson & Johnson Vaccine Use for Possible Blood Clot Link The U.S. Food and Drug Administration (FDA) on Tuesday asked states to temporarily pause using the one-dose coronavirus vaccine developed by Johnson & Johnson

Market Update: Stocks Rise Mostly Higher, Reopening Optimism Harmed by J&J Vaccine Pause Stocks traded mostly higher on Tuesday, with the Nasdaq outperforming and the S&P 500 notching a new record closing high, after a March inflation report was close to expectations...

AstraZeneca COVID Vaccine Linked to "Very Rare" Blood Clots AstraZeneca's (AZN&nbsp...

California to Reopen by June 15, Says Governor Newsom California plans to begin reopening its economy by June 15, as long as there is enough vaccine supply for everyone who wants one in the state and hospitalization rates remain low...

What Happened to 15 Million Doses of Johnson & Johnson's COVID Vaccine? The Biden administration has put Johnson & Johnson (

CDC Eases Domestic Travel Recommendations for Fully Vaccinated Individuals Travel related stocks rejoiced on Monday in their first trading session since the U.S. Centers for Disease Control and Prevention (CDC) updated its guidance for domestic travel f...

President Biden Ups First 100 Days Vaccination Target to 200 Million Doses President Joe Biden announced a new goal of reaching 200 million COVID vaccinations given in the administration's first 100 days in office during his first press conference as pr...

Biden Administration Meets '100 Million Vaccines in 100 Days' Goal Early President Joe Biden announced on Thursday that his administration had met his goal of administering 100 million coronavirus vaccine shots within his first 100 days in office ahea...

U.S. to Make All Adults Eligible for COVID Vaccines by May 1 In his first primetime address, President Joe Biden announced that he has directed states to make all adults, ages 18 and up, eligible for the coronavirus vaccine by May 1. Biden...

C.D.C. Guidance Says Fully Vaccinated Individuals Can Meet Indoors Without Masks The U.S. Centers for Disease Control and Prevention (C.D.C.) released new guidance on Monday that stated that people who have been fully vaccinated against the coronavirus can me...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more